1. Antineoplastics

   Case report 24 April 2021 Pages: 51 - 51

2. Antineoplastics

   Case report 24 April 2021 Pages: 52 - 52

3. Antineoplastics

   Case report 24 April 2021 Pages: 53 - 53

4. Antineoplastics

   Case report 24 April 2021 Pages: 54 - 54

5. Antineoplastics

   Case report 24 April 2021 Pages: 55 - 55

6. Antineoplastics

   Case report 24 April 2021 Pages: 56 - 56

7. Antineoplastics

   Case report 24 April 2021 Pages: 57 - 57

8. Antineoplastics

   Case report 24 April 2021 Pages: 58 - 58

9. Antineoplastics

   Case report 24 April 2021 Pages: 59 - 59

10. Antineoplastics

    Case report 24 April 2021 Pages: 60 - 60

11. Antineoplastics

    Case report 24 April 2021 Pages: 61 - 61

12. Antineoplastics

    Case report 24 April 2021 Pages: 62 - 62

13. Antineoplastics

    Case report 24 April 2021 Pages: 63 - 63

14. Antineoplastics/axicabtagene ciloleucel

    Case report 24 April 2021 Pages: 64 - 64

15. Antineoplastics/cefazolin

    Case report 24 April 2021 Pages: 65 - 65

16. Antineoplastics/fulvestrant/proton pump inhibitors

    Case report 24 April 2021 Pages: 66 - 66

17. Antiparkinsonians

    Case report 24 April 2021 Pages: 67 - 67

18. Antipsoriatics/isoniazid

    Case report 24 April 2021 Pages: 68 - 68

19. Antithrombotics

    Case report 24 April 2021 Pages: 69 - 69

20. Antituberculars/valpromide interaction

    Case report 24 April 2021 Pages: 70 - 70

21. Apixaban

    Case report 24 April 2021 Pages: 71 - 71

22. Aripiprazole/olanzapine/sertraline

    Case report 24 April 2021 Pages: 72 - 72

23. Arsenic-trioxide

    Case report 24 April 2021 Pages: 73 - 73

24. Arsenic-trioxide/daunorubicin/tretinoin

    Case report 24 April 2021 Pages: 74 - 74

25. Aspirin/clopidogrel

    Case report 24 April 2021 Pages: 75 - 75

26. Aspirin/clopidogrel/warfarin

    Case report 24 April 2021 Pages: 76 - 76

27. Atazanavir/ritonavir/emtricitabine/tenofovir-disoproxil-fumarate

    Case report 24 April 2021 Pages: 77 - 77

28. Atezolizumab

    Case report 24 April 2021 Pages: 78 - 78

29. Atorvastatin

    Case report 24 April 2021 Pages: 79 - 79

30. Atorvastatin/traditional-Chinese-medicine interaction

    Case report 24 April 2021 Pages: 80 - 80

31. Atovaquone/proguanil

    Case report 24 April 2021 Pages: 81 - 81

32. Avibactam/ceftazidime/cefepime/meropenem

    Case report 24 April 2021 Pages: 82 - 82

33. Axitinib/nivolumab/pazopanib

    Case report 24 April 2021 Pages: 83 - 83

34. Azacitidine

    Case report 24 April 2021 Pages: 84 - 84

35. Azacitidine

    Case report 24 April 2021 Pages: 85 - 85

36. Azathioprine

    Case report 24 April 2021 Pages: 86 - 86

37. Azathioprine/carbamazepine

    Case report 24 April 2021 Pages: 87 - 87

38. Azathioprine/infliximab/prednisolone

    Case report 24 April 2021 Pages: 88 - 88

39. Azathioprine/methotrexate/unspecified proton-pump-inhibitors

    Case report 24 April 2021 Pages: 89 - 89

40. Azathioprine/prednisolone

    Case report 24 April 2021 Pages: 90 - 90

41. Azathioprine/prednisolone

    Case report 24 April 2021 Pages: 91 - 91

42. Bcg

    Case report 24 April 2021 Pages: 92 - 92

43. Bcg-vaccine

    Case report 24 April 2021 Pages: 93 - 93

44. Bendamustine/dexamethasone

    Case report 24 April 2021 Pages: 94 - 94

45. Benralizumab/ciclosporin

    Case report 24 April 2021 Pages: 95 - 95

46. Bevacizumab/cyclophosphamide

    Case report 24 April 2021 Pages: 96 - 96

47. Binimetinib

    Case report 24 April 2021 Pages: 97 - 97

48. Binimetinib/cetuximab/encorafenib

    Case report 24 April 2021 Pages: 98 - 98

49. Bisoprolol/epinephrine

    Case report 24 April 2021 Pages: 99 - 99

50. Bisphosphonates/disease-modifying-antirheumatics/unspecified nonsteroidal-anti-inflammatories

    Case report 24 April 2021 Pages: 100 - 100